Gobstopper
New member
Hi .. this is my first post here
I just saw this article and thought ladies here would find it interesting.
Eye On Female 'Viagra'
A controversial sex patch to be worn by women suffering from "female sexual dysfunction" could be on the U.S. market this year with a $100 million (£57 million) marketing campaign, even though some physicians say the "disease" it is meant to cure does not exist.
Procter & Gamble, manufacturers of household products including Pampers diapers, says its sex patch, Intrinsa, is now in final drugs trials, and could get U.S. Food and Drug Administration approval this year.
The company's pharmaceutical division described the patch as a "potential blockbuster."
Intrinsa is a testosterone patch worn on the skin that boosts sexual desire in post-menopausal women. A male hormone, testosterone is also produced in women at lower levels and plays a crucial role in sexual desire. Like the female hormone estrogen, levels of testosterone fall after the menopause.
Other drug companies are following suit, hoping to exploit a lucrative market by creating medications intended to do for women what Viagra has done for men.
Some physicians, however, say the pharmaceutical companies create the drugs first, then invent non-existent "diseases" to sell them. "Female sexual dysfunction" was cited by a prominent medical journal as one of these invented "diseases."
An article in the British Medical Journal provoked a heated debate two weeks ago by accusing the drug industry of inventing "female sexual dysfunction" by sponsoring meetings and research.
That article also accused drug firms of profiteering by making up the new condition to play on the worries of millions of sexually dissatisfied women.
On PBS' NOW program with Bill Moyers, an American physician who had recently quit working for a pharmaceutical company to return to private practice, said the pharmaceutical companies pay doctors to put their names on research papers that the company's employees put together.
He said the doctors did not do any research at all but, with their names on papers, the pharmaceutical companies are able to place articles on the "research" at accredited medical journals.
At the company he once worked for, the doctor said, the final review of the "research papers" was not done by physicians or professional laboratory staff, but by the company's advertising agency.
These doctors are not the only one critical of "female sexual dysfunction."
"It is not arousal pills we need but a whole new kind of physical relations," said author and sex researcher Shere Hite. "The pharmaceutical industry is guilty not just of cynical money-grabbing exaggeration, it has misunderstood the basics of female sexuality."
There are no drugs currently licensed for this condition.
I just saw this article and thought ladies here would find it interesting.
Eye On Female 'Viagra'
A controversial sex patch to be worn by women suffering from "female sexual dysfunction" could be on the U.S. market this year with a $100 million (£57 million) marketing campaign, even though some physicians say the "disease" it is meant to cure does not exist.
Procter & Gamble, manufacturers of household products including Pampers diapers, says its sex patch, Intrinsa, is now in final drugs trials, and could get U.S. Food and Drug Administration approval this year.
The company's pharmaceutical division described the patch as a "potential blockbuster."
Intrinsa is a testosterone patch worn on the skin that boosts sexual desire in post-menopausal women. A male hormone, testosterone is also produced in women at lower levels and plays a crucial role in sexual desire. Like the female hormone estrogen, levels of testosterone fall after the menopause.
Other drug companies are following suit, hoping to exploit a lucrative market by creating medications intended to do for women what Viagra has done for men.
Some physicians, however, say the pharmaceutical companies create the drugs first, then invent non-existent "diseases" to sell them. "Female sexual dysfunction" was cited by a prominent medical journal as one of these invented "diseases."
An article in the British Medical Journal provoked a heated debate two weeks ago by accusing the drug industry of inventing "female sexual dysfunction" by sponsoring meetings and research.
That article also accused drug firms of profiteering by making up the new condition to play on the worries of millions of sexually dissatisfied women.
On PBS' NOW program with Bill Moyers, an American physician who had recently quit working for a pharmaceutical company to return to private practice, said the pharmaceutical companies pay doctors to put their names on research papers that the company's employees put together.
He said the doctors did not do any research at all but, with their names on papers, the pharmaceutical companies are able to place articles on the "research" at accredited medical journals.
At the company he once worked for, the doctor said, the final review of the "research papers" was not done by physicians or professional laboratory staff, but by the company's advertising agency.
These doctors are not the only one critical of "female sexual dysfunction."
"It is not arousal pills we need but a whole new kind of physical relations," said author and sex researcher Shere Hite. "The pharmaceutical industry is guilty not just of cynical money-grabbing exaggeration, it has misunderstood the basics of female sexuality."
There are no drugs currently licensed for this condition.
